Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CleanSpark Inc (CLSK) vs GeneDx Holdings Corp (WGS) Price & Performance

CleanSpark IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

CleanSpark Inc vs GeneDx Holdings Corp — how do they compare? CleanSpark Inc trades at $14.81 (market cap $3.45B), while GeneDx Holdings Corp trades at $64.44 (market cap $1.85B). The key difference: CleanSpark Inc is the larger of the two by market cap, and CleanSpark Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.

CLSKWGS
Market Cap
$3.45B$1.85B
Sector
TechnologyTechnology
52-Week High
$23.20$167.51
52-Week Low
$8.18$34.51
Enterprise Value
$4.31B$1.85B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CleanSpark Inc

CleanSpark (CLSK) trades at $12.36, down 3.81% today, with a bearish technical signal and recent earnings misses. The company reported a net loss margin of -67.66% for 2026 but announced a transformative $6.6 billion 20-year AI data center lease, shifting focus from Bitcoin mining to high-performance computing. Analyst consensus remains unanimously bullish with a $21.43 price target, highlighting growth potential despite current profitability challenges.

The outlook balances high growth potential from the AI pivot against significant execution risks and persistent losses. Near-term volatility is expected as the market assesses the company's ability to monetize new contracts and achieve sustainable profitability. The stock presents a high-risk, high-reward opportunity dependent on successful business model transition.

GeneDx Holdings Corp

GeneDx Holdings (WGS) trades at $63.85, down 2.73% amid multiple securities class action lawsuits alleging misleading acquisition performance disclosures. The stock shows bearish technical signals with support at $60 and resistance at $65. Fundamentally, the company reported negative net income of -$21.02M for 2025 despite revenue growth to $427.54M, with profitability metrics deteriorating significantly in 2026 projections.

Despite 91% analyst buy ratings and a $75.40 consensus target, substantial legal risks and negative earnings momentum create significant headwinds. The stock faces near-term pressure from litigation while long-term viability depends on reversing negative margin trends and resolving acquisition-related impairment issues that triggered the 49% stock decline cited in lawsuits.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CleanSpark Inc

CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.

Read more on CLSK

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS